Instrumentation Laboratory, Inova Diagnostics and Biokit Organizationally Transform and Now Share Werfen Name
|
By LabMedica International staff writers Posted on 13 Jul 2021 |
|
Illustration
Werfen (Barcelona, Spain) companies, including Instrumentation Laboratory (IL), Inova Diagnostics (Inova), and Biokit, are uniting under one name and one brand - Werfen. As part of this effort, the company has completed organizational transitions and adopted a new global brand identity, including a new corporate logo.
While IL, Inova and Biokit have been part of Werfen since 1992, 2009, and 1973, respectively, they will now be known simply as Werfen. The company has been known as Werfen outside of North America since 2014. The strategic hubs for the Company's key business lines will now be led by Chief Operating Officers, and operate as Werfen Headquarters and Technology Centers. Management and organization of Werfen's Commercial Operations in North America will now be consolidated. Field Service and Customer Service functions will be unified across business lines, while Sales, Applications, Marketing and Technical Support will remain specialized.
With a new logo and brand colors, Werfen adopts a new brand identity - evoking innovation and humanity. The new Werfen logo is modern, strong and singular, signifying unity in the company's quest to deliver innovation after innovation, for every patient whose life could depend upon the quality of a test result. The new logo will be incorporated into the company's products and communication vehicles gradually, over time. The legal names for IL, Inova and Biokit, and any contracts or purchasing agreements, are unaffected by this change.
"This transformation represents a natural evolution for Werfen, strengthening our global leadership position in specialized diagnostics, and positively impacting our ability to drive innovation and support our customers," said Carlos Pascual, CEO at Werfen. "By sharing one global identity, with the same vision and strategic objectives, our teams around the world will maximize collaboration to set new standards for products and services in Hemostasis, Acute Care, Autoimmunity and OEM diagnostics."
Related Links:
Werfen
While IL, Inova and Biokit have been part of Werfen since 1992, 2009, and 1973, respectively, they will now be known simply as Werfen. The company has been known as Werfen outside of North America since 2014. The strategic hubs for the Company's key business lines will now be led by Chief Operating Officers, and operate as Werfen Headquarters and Technology Centers. Management and organization of Werfen's Commercial Operations in North America will now be consolidated. Field Service and Customer Service functions will be unified across business lines, while Sales, Applications, Marketing and Technical Support will remain specialized.
With a new logo and brand colors, Werfen adopts a new brand identity - evoking innovation and humanity. The new Werfen logo is modern, strong and singular, signifying unity in the company's quest to deliver innovation after innovation, for every patient whose life could depend upon the quality of a test result. The new logo will be incorporated into the company's products and communication vehicles gradually, over time. The legal names for IL, Inova and Biokit, and any contracts or purchasing agreements, are unaffected by this change.
"This transformation represents a natural evolution for Werfen, strengthening our global leadership position in specialized diagnostics, and positively impacting our ability to drive innovation and support our customers," said Carlos Pascual, CEO at Werfen. "By sharing one global identity, with the same vision and strategic objectives, our teams around the world will maximize collaboration to set new standards for products and services in Hemostasis, Acute Care, Autoimmunity and OEM diagnostics."
Related Links:
Werfen
New
Gold Member
C-Reactive Protein Reagent
CRP Ultra Wide Range Reagent Kit
New
Incubator
HettCube 120
New
Chlamydia Test Kit
CHLAMYTOP
Latest Industry News
- Beckman Coulter Partners with BioPorto for Global Distribution of Acute Kidney Injury NGAL Tests
- CACLP 2025 New Date and Venue Announced
- Roche to Develop New Diagnostic Technologies for Traumatic Brain Injuries
- LGC Clinical Diagnostics and AccuGenomics Collaborate on Enhancing Cancer Testing Accuracy
- Beckman Coulter and SphingoTec Partner to Improve Kidney Health Assessment in Critical Care
- Seegene and Werfen Finalize Partnership Agreement on Technology-Sharing Initiative
- Cepheid Partners with Fleming Initiative to Fight Antimicrobial Resistance
- MEDICA LABMED FORUM 2024: International Experts Meet to Discuss Trending Topics in Laboratory Medicine
- Nova Biomedical and Terumo BCT Collaborate on Automated Cell Culture Sensing
- Beckman Coulter and Scopio Labs Add World's First Digital Bone Marrow Imaging and Analysis to Long-Term Partnership
- Roche Expands Digital Pathology Open Environment with Integration of Advanced AI Algorithms from New Collaborators
- Qiagen and Eli Lilly to Develop First QIAstat-Dx IVD Panel for Neurodegenerative Applications
- QIAGEN and AstraZeneca Expand Collaboration into New Disease Areas
- MEDICA 2024 + COMPAMED 2024: Adapted Hall Layout for Better Integration
- Global Coagulation Testing Driven by Increasing Blood Disorders and Surgical Interventions
- Sysmex and QIAGEN Expand Collaboration in Genetic Testing
Channels
Clinical Chemistry
view channel.jpg "Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)")
POC Saliva Testing Device Predicts Heart Failure in 15 Minutes
Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more
Screening Tool Detects Multiple Health Conditions from Single Blood Drop
Infrared spectroscopy, a method using infrared light to study the molecular composition of substances, has been a foundational tool in chemistry for decades, functioning similarly to a molecular fingerprinting... Read more
Integrated Chemistry and Immunoassay Analyzer with Extensive Assay Menu Offers Flexibility, Scalability and Data Commutability
As global healthcare systems increasingly shift towards networked laboratory operational models to enhance efficiency and patient access, there is a greater need for innovative solutions tailored to the... Read more
Molecular Diagnostics
view channel
Respiratory Panel to Help Clinicians Make Precise Treatment Decisions in Outpatient Settings
Respiratory tract infections are the primary reason for visits to emergency departments and subsequent hospitalizations. In the U.S., it is estimated that there are up to 41 million cases of influenza... Read more
Integrating Cardiovascular Risk Biomarkers Aids in Detection of ‘Inflammaging’
Cardiovascular diseases (CVD) continue to be the leading cause of death globally, responsible for nearly one-third of all fatalities worldwide. Traditionally, risk assessment for CVD has focused on well-established... Read more
Genetic Signature in Newborns Predicts Neonatal Sepsis Before Symptoms Appear
Neonatal sepsis, which occurs due to the body’s abnormal response to severe infection within the first 28 days of life, results in approximately 200,000 deaths globally each year. This condition affects around 1.... Read more.jpeg "Image: Researchers integrated multiple protein markers to predict health outcomes in individuals with chronic kidney disease (Photo courtesy of Adobe Stock)")
Integrating Multiple Protein Markers Predicts Health Outcomes in Chronic Kidney Disease Patients
Previous attempts to discover novel kidney biomarkers as risk factors for chronic kidney disease (CKD) progression have generally focused on evaluating proteins individually, which limits their prognostic... Read moreHematology
view channel
Next Gen CBC and Sepsis Diagnostic System Targets Faster, Earlier, Easier Results
Every hour is critical in protecting patients from infections, yet there are currently limited tools to assist in early diagnosis before patients reach a hospital. The complete blood count (CBC) is a common... Read more
Newly Discovered Blood Group System to Help Identify and Treat Rare Patients
The AnWj blood group antigen, a surface marker discovered in 1972, has remained a mystery regarding its genetic origin—until now. The most common cause of being AnWj-negative is linked to hematological... Read more
Blood Platelet Score Detects Previously Unmeasured Risk of Heart Attack and Stroke
Platelets, which are cell fragments circulating in the blood, play a critical role in clot formation to stop bleeding. However, in some individuals, platelets can become "hyperreactive," leading to excessive... Read more
Immunology
view channel
Computational Tool Predicts Immunotherapy Outcomes for Metastatic Breast Cancer Patients
Immunotherapy aims to enhance the body’s immune response to target cancer cells, but not all patients experience a positive reaction to such treatments. Identifying which patients will benefit from immunotherapy... Read more
Biomarker Could Predict Immunotherapy Response in Liver Cancer
Until recently, patients diagnosed with hepatocellular carcinoma had limited treatment options, with existing therapies extending life by only a few months. Immunotherapy has emerged as a new alternative... Read more
Epigenetic Test Could Determine Efficacy of New Immunotherapy Treatments Against Multiple Myeloma
Multiple myeloma is a blood cancer that primarily affects individuals over the age of sixty, and its occurrence rises as the population ages. In this disease, the bone marrow—the spongy tissue inside bones... Read more
Microbiology
view channel
High-Accuracy Bedside Test to Diagnose Periprosthetic Joint Infection in Five Minutes
Periprosthetic joint infection (PJI) represents a significant global issue that is worsening as the number of joint replacements increases due to aging populations. In the United States alone, the anticipated... Read more_1.jpg "Image: Researchers have developed a method to quickly identify the most appropriate treatments for bacterial infections (Photo courtesy of Shutterstock)")
Innovative Diagnostic Approach for Bacterial Infections to Enable Faster and Effective Treatment
For patients with bacterial infections, timely treatment with the appropriate antibiotics significantly improves their chances of recovery. Current methods for identifying which antibiotics will be effective... Read more
Non-Invasive Stool Test to Diagnose Endometriosis and Help Reduce Disease Progression
Endometriosis, a painful condition impacting nearly 200 million women globally, occurs when tissue similar to the lining of the uterus grows outside its usual location, such as on the intestines or the... Read more
Automated Positive Blood Culture Sample Preparation Platform Designed to Fight Against Sepsis and AMR
Delayed administration of antibiotics to patients with bloodstream infections significantly increases the risk of morbidity and mortality. For optimal therapeutic outcomes, it is crucial to rapidly identify... Read morePathology
view channel
New Imaging Method Opens Door to Precision Diagnostics for Head and Neck Cancers
Head and neck cancers, while considered rare, represent a significant portion of cancer cases and have seen a notable increase over the past 30 years. These cancers encompass various malignant tumors that... Read more
Faster Measurement of Vibrational Fingerprint of Molecules to Advance Biomedical Diagnostics
Identifying different types of molecules and cells is a vital process in both basic and applied science. Raman spectroscopy serves as a widely utilized measurement technique for this purpose.... Read more
Technology
view channel
New Noninvasive Methods Detect Lead Exposure Faster, Easier and More Accurately at POC
Exposure to lead can negatively affect health in multiple ways, leading to damage in the brain and central nervous system, delays in development and growth, learning and behavioral issues, problems with... Read more
